Oaktree Specialty Lending Corporation
OCSLOaktree Specialty Lending Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it.
The sharpest disagreement: the price moved −10.5% in a year while annual EPS moved −45.8% — the difference is re-rating, and re-rating has to be repaid with earnings.
The price is between stages while the P/BV sits at the 47th percentile of its own 1-year range. Underneath, the last four quarters read deteriorating — profit −25.0% year on year, with the the net margin at 42.9%. What settles it: whether earnings grow into a price that has already moved.
Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.
Oaktree Specialty Lending Corporation trades at $12.1, between stages. That is −2.2% against its own 200-day average. It sits at 39% of a 52-week range of $11 to $14. On relative strength it is currently behind the S&P 500 on a trailing-13-week view (14 weeks and counting).
Today the stock is between stages. At $12.1 it trades −2.2% versus its 200-day average and sits at 39% of its 52-week range ($11–$14).
Against the market, two honest reads. Cumulative: over the last 1.1 years the stock moved −16% while the S&P 500 moved +24% — behind the index over the full window. Recent form: on a trailing-13-week view the stock is currently behind (14 weeks and counting; last ahead the week of 2026-05-01) — the ribbon below is that same metric, week by week.
What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.
Valuation For a bank we price the book, not the earnings: P/BV is what the market pays for each $1 of the bank's net worth. A bank below 1× book is priced below the value of what it owns, net of what it owes.
Oaktree Specialty Lending Corporation trades at 0.8× P/BV, mid-range by its own standards (47th percentile). Its long-run median P/BV is 0.8×, measured across 1.1 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.
Today's P/BV of 0.8× is mid-range by its own standards (47th percentile), against a long-run median of 0.8× measured over 1.1 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.
The honest context for that discount: a bank earning about 4% on its equity is worth less per dollar of book, and the market has priced that in rather than overlooked it. The discount closes only if the returns themselves improve.
🚨 Why the multiple sits where it does: over the past year book value grew while the price moved −10.5% — price and book moved together, holding the multiple in its range.
Put together: the multiple is unremarkable against its own past, so the story rests on the book-value line underneath it, not the multiple.
Stage: Deteriorating Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).
Oaktree Specialty Lending Corporation reads as deteriorating on its fundamental arc. Deteriorating — revenue and profit growth are shrinking (revenue growth −11.4% latest against +52.0% at its 12-quarter best), ROE holding at 10.1%. The read is built from 12 quarters across 4 curves, on full evidence.
🚨 Why it matters: falling curves mean every cheap-looking ratio below needs a discount for direction.
| 1yr | 3yr | 5yr | 10yr | |
|---|---|---|---|---|
| Revenue | −15.8% | +7.2% | — | — |
| Profit | −16.7% | +0.0% | — | — |
| EPS | −45.8% | −6.7% | — | — |
| Stock price | −10.5% | — | — | — |
4-Factor Sector Score
No sector-relative score — Oaktree Specialty Lending Corporation is not among the largest members shown in this industry comparison for Asset Management.
The score is a rank WITHIN a peer set: every metric is scored by percentile against the other members. Without the peer set there is no score to state, so none is invented here.
Revenue For a bank, revenue is everything the franchise earns — interest on the loan book plus fees from its businesses.
Oaktree Specialty Lending Corporation reported $0.1 B of income in the Mar 26 quarter, −12.5% year on year. Over 4 years it has compounded at 11.1% a year. The last full year, FY25, came in at $0.3 B. The last four reported quarters add to $0.3 B.
FY25 revenue came in at $0.3 B (−15.8% on the year), capping 4 years at 11.1% compound. The latest quarter (Mar 26) printed $0.1 B, −12.5% year on year.
Pace check: the last four quarters averaged −11.4% growth against the decade's 11.1% — the current year is running slower than its own long-run rate.
Acceleration check: trailing-twelve-month revenue grew −11.4% over the last 4 quarters against −10.8%/yr over the last 8 — stabilising; TTM profit −12.5% vs −11.8%/yr — stabilising.
Net margin Net margin — what the bank keeps of every $100 of revenue after every cost, provision and tax. With big fee businesses in the mix, it is the cleanest margin we can read for this bank.
Oaktree Specialty Lending Corporation's net margin is 42.9% in the Mar 26 quarter, −7.1 percentage points against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 46.9% to 57.7%. The current quarter is running below every full year in that window.
The latest quarter's net margin is 42.9%, −7.1 pp against the same quarter a year ago. Across 5 fiscal years the net margin has ranged 46.9%–57.7%.
Why: the numbers show the net margin move clearly, but the cost lines behind it sit below what we hold — so we state the move without inventing its driver.
Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.
Oaktree Specialty Lending Corporation earned $0.0 B of net profit in the Mar 26 quarter, −25.0% year on year. Full-year FY25 profit was $0.1 B. The 4-year compound rate is 10.7%. That is 42.9% of the quarter's revenue. The same quarter a year earlier earned $0.0 B.
Mar 26 profit was $0.0 B, −25.0% year on year. On the full year, FY25 printed $0.1 B (−16.7%), and the 4-year compound rate is 10.7%.
🚨 Why profit moved: revenue contributed −12.5% and the margin −7.1 pp — the quarter was revenue-led despite a thinner margin.
Pace comparison, last four quarters: profit −12.5% vs revenue −11.4%. Profit and revenue are moving roughly in step.
Asset quality — the ladder Gross NPA is the slice of the loan book where repayments have stopped. Net NPA is what remains after the money already set aside against those loans. Falling is healing; rising is damage arriving.
Loan-book quality history is not available for Oaktree Specialty Lending Corporation, so this section names the gap rather than estimating a ratio. No gross or net non-performing-asset series is filed in a form this page can read, and none is inferred from the profit line. The income, margin and return sections above carry the evidence this business does report.
We do not hold quarterly loan-book quality numbers for this bank, so this section states that plainly rather than working around it.
Why: loan-book quality is the engine room of a bank, and its drivers — slippages, recoveries, provisioning — sit below what we hold for this name; the sections around it carry the reads we can stand behind.
The loan book We read the loan book through revenue — when the book and the businesses grow, revenue grows with them. It is a rough proxy, and we say so: rate moves and fee swings can shift it a few points in any one year.
Oaktree Specialty Lending Corporation's revenue grew −15.8% in FY25 to $0.3 B, so the book is flat. The latest quarter ran −12.5% year on year. The net margin on that income is 42.9%, −7.1 percentage points against a year ago. Interest income is a proxy for the book; rate moves can shift it a few points in any one year.
FY25 revenue was $0.3 B, −15.8% on the year, and the latest quarter ran −12.5% year on year. The net margin on that revenue is 42.9% this quarter (−7.1 pp YoY) — growth with a narrowing margin on it.
The synthesis: a lender compounds when the book grows while the margin holds and the loan book stays clean — with quarterly loan-quality numbers missing here, revenue growth and margin are the two we watch.
Returns on equity and assets Two numbers rate a bank: ROE — what it earns on shareholder money — and ROA — what it earns on everything it deploys. ROE above ~13–15% earns its keep; below that, growth builds book slowly.
Oaktree Specialty Lending Corporation earns a return on equity of 10% in FY25. Its trough over the ladder below was 8% in FY21. On the asset side every $100 of the balance sheet earned about $5.23, which is the return before leverage is applied.
FY25 ROE came in at 10%, recovered from a FY21 trough of 8%. On assets, the latest reading is about 5.23% — every $100 the bank deploys earns roughly $5.23 a year. That return is below the bar a bank must clear to compound book value quickly — which is also the honest reason the stock trades where it does.
Why ROE moved: profit compounded 10.7% a year over 4 years while the equity base grew more slowly — earnings recovering faster than book value builds is what lifts ROE off a trough.
Dividend A dividend is cash paid out per share. Dividend per share is the declared amount for the period; the trailing twelve-month total is the four most recent quarters added together.
Oaktree Specialty Lending Corporation paid $1.60 per share over the last four reported quarters, down 27.3% on a year ago. The most recent declaration was $0.40 for Mar 26. Against the current price of $12.1 that is a trailing yield of 13.19%, measured on dividends already paid rather than on a forecast.
Oaktree Specialty Lending Corporation paid $1.60 per share across the last four reported quarters, most recently $0.40 for Mar 26. That is down 27.3% against the same quarter a year earlier. Against the current price of $12.1 the trailing twelve months work out to 13.19% — trailing dividends measured against today's price, not a forward estimate.
Debt
For a bank, borrowings are raw material, not a warning sign — solvency is read through the returns and the loan book. A manufacturer’s debt is a claim against its profits, so the debt-to-equity lens that works everywhere else misleads on a lender and is not applied here.
A manufacturer’s debt is a claim against its profits; a bank’s borrowings are its inventory — money taken in to be lent out. The debt lens that works everywhere else misleads here, so this page does not apply it. The solvency questions for a bank — is the loan book sound, is the equity earning — are read through the loan-book and returns sections above.
Ownership There is no quarter-by-quarter holder register to read here, so we read the crowd through short interest — the slice of tradable shares currently sold short, positioned for a fall.
No ownership or positioning reading is held for Oaktree Specialty Lending Corporation, so this section names the gap rather than filling it. At typical trading volumes those positions would take about 6.9 days to buy back. There is no quarter-by-quarter holder register to read for this filer, so the crowd is read through short interest instead.
We hold no ownership or positioning reading for this stock, so this section says that plainly.
Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.
Oaktree Specialty Lending Corporation: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre. The Z-score was built for manufacturers and is not applied to banks and lenders, so solvency here is read from the capital and asset-quality lines instead.
The safety line in one sentence: the Z-score is omitted — it was built for manufacturers, not banks, and applying it here would be theatre.
No sector comparison is shown here — not among the largest members shown in this industry comparison.
Frequently asked questions
What is Oaktree Specialty Lending Corporation's stock price today?
Oaktree Specialty Lending Corporation trades at $12.1, −10.5% over the past year. The company is valued at $1.0 B. The stock sits at 39% of its 52-week range of $11–$14, −2.2% versus its 200-day average. Against the S&P 500 it has been behind on a trailing-13-week view for 14 weeks. — as of 5 August 2026.
What were Oaktree Specialty Lending Corporation's latest quarterly results?
Oaktree Specialty Lending Corporation reported total income of $0.1 B and net profit of $0.0 B for the Mar 26 quarter. Income fell 12.5% and profit fell 25.0% year on year. The net margin was 42.9%, 7.1 pp lower than a year earlier. — as of 5 August 2026.
What is Oaktree Specialty Lending Corporation's revenue?
Oaktree Specialty Lending Corporation reported revenue of $0.1 B in the Mar 26 quarter, −12.5% year on year. For the full FY25 fiscal year, revenue was $0.3 B (−15.8%). Over the last 4 years revenue compounded at 11.1% a year. — as of 5 August 2026.
What is Oaktree Specialty Lending Corporation's profit?
Oaktree Specialty Lending Corporation earned $0.0 B of net profit in the Mar 26 quarter, −25.0% year on year. Full-year FY25 profit was $0.1 B. The net margin ran 42.9% in the latest quarter. — as of 5 August 2026.
What is Oaktree Specialty Lending Corporation's market cap?
Oaktree Specialty Lending Corporation's market capitalisation is $1.0 B at a stock price of $12.1. Market cap is the share price multiplied by shares outstanding, so it is restated whenever the price moves. — as of 5 August 2026.
What is Oaktree Specialty Lending Corporation's P/BV ratio?
Oaktree Specialty Lending Corporation trades at a P/BV of 0.8×, at the 47th percentile of its own 1-year range, against a long-run median of 0.8×. This is a comparison with the stock's own history, not a value call — as of 5 August 2026.
Does Oaktree Specialty Lending Corporation pay a dividend?
Yes — Oaktree Specialty Lending Corporation declared $0.40 per share for Mar 26, and $1.60 per share across the last four reported quarters. The latest quarter is down 27.3% on the same quarter a year earlier. — as of 5 August 2026.
What is Oaktree Specialty Lending Corporation's dividend per share?
Oaktree Specialty Lending Corporation's most recently declared dividend is $0.40 per share for Mar 26, giving $1.60 per share over the trailing twelve months. Each figure is the amount declared for that quarter as reported, added across four quarters for the trailing total. — as of 5 August 2026.
What is Oaktree Specialty Lending Corporation's dividend yield?
Oaktree Specialty Lending Corporation's trailing dividend yield is 13.19%: $1.60 declared per share across the last four reported quarters, against a share price of $12.1. Each quarter’s figure is the amount declared for that quarter as reported, added across four quarters and divided by the latest close. — as of 5 August 2026.
Is Oaktree Specialty Lending Corporation overvalued?
On its own history, Oaktree Specialty Lending Corporation looks mid-range against its own history: its P/BV of 0.8× sits at the 47th percentile of its 1-year range (long-run median 0.8×). That is a percentile read against the stock's own past, not a price opinion or a direction call. — as of 5 August 2026.
Is Oaktree Specialty Lending Corporation growing?
Not right now — Oaktree Specialty Lending Corporation's latest numbers are shrinking: latest-quarter revenue −12.5% year on year, profit −25.0%, and the the net margin −7.1 pp at 42.9%. The 4-year compound rates are 11.1% (revenue) and 10.7% (profit). The earnings engine currently reads: deteriorating — as of 5 August 2026.
How is Oaktree Specialty Lending Corporation performing?
Oaktree Specialty Lending Corporation's latest readings are below. Its latest quarter's income fell 12.5% and profit fell 25.0% year on year. Against the S&P 500 it has been behind on a trailing-13-week view for 14 weeks. This describes what the data did, not a rating. — as of 5 August 2026.
What stage is Oaktree Specialty Lending Corporation in?
Deteriorating — revenue and profit growth are shrinking (revenue growth −11.4% latest against +52.0% at its 12-quarter best), ROE holding at 10.1%. The read comes from the last 12 quarters of growth (revenue growth −11.4% latest, profit growth −12.5% latest, eps growth +338.5% latest) plus the ROE curve, classified by deterministic rules — a trajectory read, not a buy or sell call — as of 5 August 2026.
Is Oaktree Specialty Lending Corporation beating the market?
Not lately — on a trailing-13-week view Oaktree Specialty Lending Corporation is currently behind the S&P 500 (14 weeks and counting; last ahead the week of 2026-05-01), the same metric the week-by-week ribbon on this page draws. Separately, on the cumulative view: over the last 1.1 years the stock moved −16% against the S&P 500's +24% — behind the index over the full window. — as of 5 August 2026.
Will Oaktree Specialty Lending Corporation's stock price go up?
This page publishes no price forecast for Oaktree Specialty Lending Corporation. What it measures instead: the stock price is $12.1. Its P/BV of 0.8× sits at the 47th percentile of its own 1-year range. Direction is not something this site claims to know. — as of 5 August 2026.
Is Oaktree Specialty Lending Corporation's loan book healthy?
We do not hold quarterly loan-book quality numbers for Oaktree Specialty Lending Corporation, so this page says that plainly. The cleanest available reads are revenue growth (−15.8% in FY25) and the net margin on it (42.9%) — as of 5 August 2026.
Where is Oaktree Specialty Lending Corporation in its business cycle?
Oaktree Specialty Lending Corporation's FY25 net margin was 46.9%, against a 5-year band of 46.9%–57.7%: the low end of its own band, which is where recoveries start when they come. The latest quarter ran 42.9%. Profitability versus a company's own long band is the cleanest cycle clock this page holds — as of 5 August 2026.
What could break the Oaktree Specialty Lending Corporation story?
The sharpest disagreement: the price moved −10.5% in a year while annual EPS moved −45.8% — the difference is re-rating, and re-rating has to be repaid with earnings. Mechanically, two Friday closes in a row below the 200-day average would end the price trend — that is the exit rule this page tracks — as of 5 August 2026.
Is Oaktree Specialty Lending Corporation a stock worth studying right now?
This is not investment advice. The machine read: Oaktree Specialty Lending Corporation's three tracks disagree. Price, valuation and the earnings engine each tell a different story — the next quarter or two settles it. The sharpest open question: whether earnings grow into a price that has already moved. Every number on this page is drawn deterministically from the raw series, with no forecasts and no price opinions — as of 5 August 2026.